1Biffi, R. , et al. , Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients[J]. Annals of oncology, 2004,15(2): 296.
2Bouza, E.A. Burillo, and P. Munoz, Catheter-related infections:diagnosis and intravascular treatment[J]. Clinical Microbiology and Infection, 2002,8(5): 265-274.
3Bouza, E. A European perspective on intravascular catheter--related infections: report on the microbiology workload, aetiology and antimicrobial susceptibility (ESGNI-005 Study) [J]. Clinical Microbiology and Infection, 2004,10(9) : 838-842.
4Oliver, M. Risk of baeteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study [J]. Kidney international, 2000,58(6) : 2543-2545.
5Salgado, O. Right versus left internal jugular vein catheterization for hemodialysis: complications and impact on ipsilateral access creation[J]. Artificial organs, 2004,28(8) : 728-733.
6Pratt, R. National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England[J]. Journal of hospital infection, 2007,65: S 1-S 59.
7Bagnall-Reeb, H. , Evidence for the use of the antibiotic lock technique[J]. Journal of Infusion Nursing, 2004,27(2) : 118.
8Kurul, S. , P. Saip, and T. Aydin, Totally implantable venousaccess ports: local problems and extravasation injury[J]. Lancet Oncology, 2002,3(11) : 684-692.
9Kreis, H. , et al. , Patients' attitudes to totally implantable venous access port systems for gynecological or breast malignancies [J]. European Journal of Surgical Oneology (EJSO), 2007,33 ( 1 ):39- 43.
10Cortelezzi, A. , et al. , Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study[J]. British journal of haematology, 2005,129(6) :811-817.
